Wave Life Sciences
88 hedge funds and large institutions have $184M invested in Wave Life Sciences in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 12 closing their positions.
142% more call options, than puts
Call options by funds: $633K | Put options by funds: $262K
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
1% more funds holding
Funds holding: 87 → 88 (+1)
0.1% more ownership
Funds ownership: 73.63% → 73.72% (+0.1%)
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
25% less capital invested
Capital invested by funds: $246M → $184M (-$62.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$6.06M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$6.02M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$3.45M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.43M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$9.79M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.85M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.6M |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$2.08M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$942K |
WVE Hedge Fund Activity: Q3 2021 in Review
88 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2021, worth a combined $184M — down 25% from $246M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new WVE positions and 12 closed out — a net gain of 2 holders — while 24 added to existing stakes and 29 trimmed.
The largest buyer was Artal Group, opening a new position worth an estimated $6.06M. The largest seller was Deerfield Management, cutting an estimated $9.79M.
- 88 institutional investors held Wave Life Sciences (WVE) as of Q3 2021, up from 87 in Q2 2021.
- Funds reported $184M of Wave Life Sciences stock for Q3 2021, down 25% quarter-over-quarter.
- 14 funds opened new Wave Life Sciences positions in Q3 2021 and 12 closed out, a net change of +2 holders.
- The largest Wave Life Sciences buyer in Q3 2021 was Artal Group, an estimated $6.06M added.
- The largest Wave Life Sciences seller in Q3 2021 was Deerfield Management, an estimated $9.79M sold.
Based on aggregated 13F filings for Q3 2021.